Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Patient-derived xenograft culture-transplant system for investigation of human breast cancer metastasis

ABSTRACT: Patient-derived xenograft culture-transplant system for investigation of human breast cancer metastasis

PROVIDER: PRJNA644401 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR12158632_1.fastq.gz	Fastqsanger.gz
	SRR12158632_2.fastq.gz	Fastqsanger.gz
	SRR12158633_1.fastq.gz	Fastqsanger.gz
	SRR12158633_2.fastq.gz	Fastqsanger.gz
	SRR12158634_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

Patient-derived xenograft culture-transplant system for investigation of human breast cancer metastasis.

Project description:Metastasis is a fatal disease where research progress has been hindered by a lack of authentic experimental models. Here, we develop a 3D tumor sphere culture-transplant system that facilitates the growth and engineering of patient-derived xenograft (PDX) tumor cells for functional metastasis assays in vivo. Orthotopic transplantation and RNA sequencing (RNA-seq) analyses show that PDX tumor spheres maintain tumorigenic potential, and the molecular marker and global transcriptome signatures of native tumor cells. Tumor spheres display robust capacity for lentiviral engineering and dissemination in spontaneous and experimental metastasis assays in vivo. Inhibition of pathways previously reported to attenuate metastasis also inhibit metastasis after sphere culture, validating our approach for authentic investigations of metastasis. Finally, we demonstrate a new role for the metabolic enzyme NME1 in promoting breast cancer metastasis, providing proof-of-principle that our culture-transplant system can be used for authentic propagation and engineering of patient tumor cells for functional studies of metastasis.

| S-EPMC8571269 | biostudies-literature

Patient-derived xenograft culture-transplant system for investigation of human breast cancer metastasis

Project description:We report a new method for culturing patient breast tumor cells in vitro, for subsequent transplantation in vivo for experimental metastasis assays. RNA sequencing shows that tumor spheres formed in culture maintain the fundamental properties of native tumor cells.

2020-07-07 | GSE153887 | GEO

Medulloblastoma Patient-Derived Xenograft Proteomics

Project description:Proteomic and phosphoproteomic characterization of 20 orthotopic patient-derived xenograft models of medulloblastoma

2022-09-01 | PXD035070 | Pride

Molecular investigation of Breast Cancer xenograft model exposed to proton radiations

Project description:Molecular investigation of Breast Cancer xenograft model exposed to proton radiations

| PRJNA627172 | ENA

Texas Pediatric Patient Derived Xenograft

Project description:Texas Pediatric Patient Derived Xenograft

| PRJNA939343 | ENA

Proteomic Profiling of Breast Cancer Patient-Derived Xenograft

Project description:Mass spectrometry profiling of orthotopically transplanted breast cancer patient-derived xenograft (PDX) tumors prior to chemotherapy treatment.

2022-12-06 | PXD035857 | Pride

Expression data from post-transplant lymphoproliferative disorder (PTLD) patient samples

Project description:In this study we focussed on malignant post-transplant lymphomas. Post-transplant lymphoma is strongly associated with Epstein-Barr Virus (EBV) infection in contrast to lymphoma arising in an immunocompetent population. Nevertheless, about 1 in 3 PTLD cases are negative for EBV. We used a microarray to define the gene expression profile of different PTLDs to elucidate the pathogenesis of EBV(+) and EBV(-) PTLD and to define whether EBV(-) PTLD is biologically different from EBV(-) lymphoma arising in an immunocompetent host. PTLD patient samples were randomly selected for RNA extraction and hybridization on an Affymetrix platform. The post-transplant tumors consisted of homogenous sheets of neoplastic cells ensuring reliability of the gene expression data.

2012-06-22 | E-GEOD-38885 | biostudies-arrayexpress

Expression data from post-transplant lymphoproliferative disorder (PTLD) patient samples

2012-06-23 | GSE38885 | GEO

Affymetrix SNP array data for kidney transplant samples

Project description:Tacrolimus (TAC) is an immunosuppressant widely used in kidney transplantation. TAC displays considerable inter-individual variability in pharmacokinetics (PK). Genetic and clinical factors play important roles in TAC PK. To define genetic factors associated with tacrolimus blood trough concentration, we performed a genome-wide association study of renal transplant samples from 251 Chinese renal transplant recipients. We identified 23 single nucleotide polymorphisms (SNPs) related to TAC PK variability. All 23 genome-wide significant SNPs (p<5E-8) were located on chromosome 7, including rs776746. These findings suggest that these SNPs may be associated with the unexlained TAC PK variability in renal transplant recipients and require further investigation.

2022-02-24 | GSE196772 | GEO

Lung transplant

Project description:Lung transplant

| PRJNA827139 | ENA